Preferred Name |
Cisatracurium |
|
Synonyms |
|
|
Definitions |
A non-depolarizing skeletal muscle relaxant of the benzylisoquinolinium class, with skeletal muscle relaxing activity. Cisatracurium besylate acts as a competitive acetylcholine antagonist that binds to nicotinic receptors at the neuromuscular junction. This blocks neuromuscular transmission and causes neuromuscular relaxation. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C77365 |
|
CAS_Registry |
96946-41-7 |
|
Chemical_Formula |
C53H72N2O12 |
|
code |
C77365 |
|
Contributing_Source |
FDA |
|
definition |
A non-depolarizing skeletal muscle relaxant of the benzylisoquinolinium class, with skeletal muscle relaxing activity. Cisatracurium besylate acts as a competitive acetylcholine antagonist that binds to nicotinic receptors at the neuromuscular junction. This blocks neuromuscular transmission and causes neuromuscular relaxation. |
|
FDA_UNII_Code |
QX62KLI41N |
|
Has_Salt_Form | ||
in_subset | ||
label |
Cisatracurium |
|
Legacy Concept Name |
Cisatracurium |
|
Preferred_Name |
Cisatracurium |
|
prefixIRI |
NCIT:C77365 |
|
prefLabel |
Cisatracurium |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C1096766 |
|
subClassOf |